You have no items in your shopping cart.
All Products
- Recombinant Human CD44 (C-Fc) [orb2994009]
Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 49.2 KDa. Observed: 75-95 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human CD40 (C-Fc) [orb2994010]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 46.3 KDa. Observed: 50-65 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human IFNAR2 (C-Fc) [orb2994011]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 51.8 KDa. Observed: 67-75 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human CD99 (C-Fc) [orb2994012]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 37.2 KDa. Observed: 58 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Rhesus Macaque B7-H4 (C-6His) [orb2994013]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 26.4 KDa. Observed: 40-60 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human TREML1 (C-Fc) [orb2994014]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 42.9 KDa. Observed: 50-60 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human BTLA (C-Fc) [orb2994015]
Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 40.9 KDa. Observed: 55 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human Follistatin 288 (C-6His) [orb2994016]
Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 32.4 KDa. Observed: 33-42 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human MANF (C-6His) [orb2994017]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 18.99 KDa. Observed: 17 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Sheep PRL (C-6His) [orb2994018]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 23.5 KDa. Observed: 25-30 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg